» Articles » PMID: 32149271

Polymer-Peptide Conjugates Convert Amyloid into Protein Nanobundles Through Fragmentation and Lateral Association

Overview
Date 2020 Mar 10
PMID 32149271
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The assembly of proteins into amyloid fibrils has become linked not only with the progression of myriad human diseases, but also important biological functions. Understanding and controlling the formation, structure, and stability of amyloid fibrils is therefore a major scientific goal. Here we utilize electron microscopy-based approaches combined with quantitative statistical analysis to show how recently developed kind of amyloid modulators-multivalent polymer-peptide conjugates (mPPCs)-can be applied to control the structure and stability of amyloid fibrils. In doing so, we demonstrate that mPPCs are able to convert 40-residue amyloid beta fibrils into ordered nanostructures through a combination of fragmentation and bundling. Fragmentation is shown to be consistent with a model where the rate constant of fibril breakage is independent of the fibril length, suggesting a local and specific interaction between fibrils and mPPCs. Subsequent bundling, which was previously not observed, leads to the formation of sheet-like nanostructures which are surprisingly much more uniform than the starting fibrils. These nanostructures have dimensions independent of the molecular weight of the mPPC and retain the molecular-level ordering of the starting amyloid fibrils. Collectively, we reveal quantitative and nanoscopic understanding of how mPPCs can be applied to control amyloid structure and stability, and demonstrate approaches to elucidate nanoscale amyloid phase behavior in the presence of functional macromolecules and other modulators.

Citing Articles

Ferumoxytol nanozymes effectively target chronic biofilm infections in apical periodontitis.

Babeer A, Liu Y, Ren Z, Xiang Z, Oh M, Pandey N J Clin Invest. 2024; 135(3).

PMID: 39589820 PMC: 11785919. DOI: 10.1172/JCI183576.


Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Nguyen P, Ramamoorthy A, Sahoo B, Zheng J, Faller P, Straub J Chem Rev. 2021; 121(4):2545-2647.

PMID: 33543942 PMC: 8836097. DOI: 10.1021/acs.chemrev.0c01122.


Multivalent Polymer-Peptide Conjugates-A General Platform for Inhibiting Amyloid Beta Peptide Aggregation.

Jiang X, Halmes A, Licari G, Smith J, Song Y, Moore E ACS Macro Lett. 2020; 8(10):1365-1371.

PMID: 32149017 PMC: 7059649. DOI: 10.1021/acsmacrolett.9b00559.

References
1.
Turner M, Briehl R, Ferrone F, Josephs R . Twisted protein aggregates and disease: the stability of sickle hemoglobin fibers. Phys Rev Lett. 2003; 90(12):128103. DOI: 10.1103/PhysRevLett.90.128103. View

2.
Westermark P, Engstrom U, Johnson K, Westermark G, Betsholtz C . Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A. 1990; 87(13):5036-40. PMC: 54256. DOI: 10.1073/pnas.87.13.5036. View

3.
Yang C, Zhu X, Li J, Shi R . Exploration of the mechanism for LPFFD inhibiting the formation of beta-sheet conformation of A beta(1-42) in water. J Mol Model. 2010; 16(4):813-21. DOI: 10.1007/s00894-009-0594-y. View

4.
Sen A, Baxa U, Simon M, Wall J, Sabate R, Saupe S . Mass analysis by scanning transmission electron microscopy and electron diffraction validate predictions of stacked beta-solenoid model of HET-s prion fibrils. J Biol Chem. 2006; 282(8):5545-50. DOI: 10.1074/jbc.M611464200. View

5.
Sweers K, Bennink M, Subramaniam V . Nanomechanical properties of single amyloid fibrils. J Phys Condens Matter. 2012; 24(24):243101. DOI: 10.1088/0953-8984/24/24/243101. View